Dyne Therapeutics Inc (DYN)

Finanzdaten der Dyne Therapeutics Inc-Aktie (DYN)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	2.17% 69.16	67.69	62.27	66.74	45.46
Operating Income/Loss	2.17% -69.16	-67.69	-62.27	-66.74	-45.46
Income/Loss From Continuing Operations Before Tax	1.48% -65.65	-66.64	-60.21	-64.90	-44.19
Income/Loss From Continuing Operations After Tax	1.48% -65.65	-66.64	-60.21	-64.90	-44.19
Net Income/Loss	1.48% -65.65	-66.64	-60.21	-64.90	-44.19
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Earnings Per Share	25.69% -0.81	-1.09	-0.99	-1.08	-0.78
Diluted Earnings Per Share	25.69% -0.81	-1.09	-0.99	-1.08	-0.78
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-